Additional file 1 of A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study
Additional file 1. Additional patient parameters (physical and biochemical parameters that showed no significant differences between the empagliflozin and sitagliptin groups).